Hartland & Co »

Avita Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $12 3 4.33
2025-09-30 $337 66 5.12

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Avita Therapeutics

Vanguard Capital Management
BlackRock
State Street Corporation
Geode Capital Management
Marshall Wace
AQR Capital Management
Vanguard Fiduciary Trust
Morgan Stanley
Goss Wealth Management
Macquarie Group
Quantinno Capital Management
Divisadero Street Capital Management
UBS Group
Goldman Sachs Group
Northern Trust

View all funds holding Avita Therapeutics